Search bioRxiv⌕ Search

Biology subjects

Hojlund, K.

Publications and source records attributed to Hojlund, K..

5 recordsLinked to original sources

Mitochondrial cristae density is increased following high-intensity interval training in patients with type 2 diabetes

Aims/hypothesisMitochondrial cristae architecture is a key determinant of oxidative capacity in skeletal muscle. While mitochondrial dysfunction is common in type 2 diabetes, it remains unclear whether cristae density is reduced and whether it can be improved by exercise training. We therefore investigated the mitochondrial cristae density in skeletal muscle of patients with type 2 diabetes compared with glucose-tolerant individuals with obesity and lean individuals, and examined the effect of high-intensity interval training (HIIT). MethodsIn a non-randomized intervention study, the effect of an 8-week supervised HIIT intervention combining rowing and cycling was examined in male participants (aged 40-65 years) with type 2 diabetes (n=15), glucose-tolerant individuals with obesity (n=15), and lean individuals (n=18). Muscle biopsies from the m. vastus lateralis were analyzed using transmission electron microscopy (TEM) to quantify mitochondrial cristae density (cristae surface area per mitochondrial volume) and to derive cristae surface area per muscle volume, integrating mitochondrial abundance and ultrastructure. To ensure high stereological precision, a minimum of 49 mitochondrial profiles per sample were analyzed. ResultsNo differences in mitochondrial cristae density were observed between groups at baseline. HIIT induced an [~]7% increase in cristae density across all groups, with the most pronounced adaptations in type 2 fibers and in the intermyofibrillar compartment. At baseline, patients with type 2 diabetes exhibited lower cristae surface area per muscle volume compared with lean individuals. Notably, cristae surface area per muscle volume increased more than mitochondrial volume density alone, reflecting combined structural and volumetric remodeling. Conclusions/interpretationSkeletal muscle mitochondrial cristae density is not different between patients with type 2 diabetes and glucose-tolerant individuals with obesity and lean individuals, and the capacity for cristae remodeling in response to exercise is not affected by type 2 diabetes. These findings highlight the plasticity of mitochondrial architecture and support HIIT as a potent stimulus for improving muscle oxidative and metabolic health, also in type 2 diabetes. Research in Context What is already known about this subject?O_LISkeletal muscle mitochondrial cristae architecture is critical for oxidative phosphorylation and metabolic health. C_LIO_LIType 2 diabetes is associated with altered mitochondrial structure, but whether cristae density is reduced remains unclear. C_LIO_LIPrevious short-term exercise interventions have shown limited or inconsistent effects on mitochondrial cristae density, possibly due to methodological constraints. C_LI What is the key question?O_LICan high-intensity interval training (HIIT) remodel skeletal muscle mitochondrial cristae in patients with type 2 diabetes, and is baseline cristae density altered in this condition? C_LI What are the new findings?O_LIBaseline mitochondrial cristae density does not differ between patients with type 2 diabetes and glucose-tolerant individuals with obesity and lean individuals, but cristae surface area per muscle volume is lower in type 2 diabetes. C_LIO_LIEight weeks of HIIT increased mitochondrial cristae density by [~]7% across all groups, with cristae surface area per muscle volume increasing more than mitochondrial volume density alone. C_LIO_LIExercise-induced cristae remodeling occurs in both muscle fiber types and subcellular compartments, demonstrating preserved structural plasticity in type 2 diabetes. C_LI How might this impact on clinical practice in the foreseeable future?O_LIHIIT represents a potent intervention to improve mitochondrial architecture and potentially enhance muscle oxidative capacity and metabolic health in individuals with type 2 diabetes. C_LI

cell biology↗

Increased contact between lipid droplets and mitochondria in skeletal muscles of male elite endurance athletes

Endurance athletes exhibit higher skeletal muscle mitochondrial and lipid droplet (LD) content compared to recreationally active individuals, along with greater whole-body oxygen uptake and maximal fat oxidation rates. In this study, we investigated if these differences manifest in a greater LD-mitochondria contact and how this may relate to the organelles size, shape, and numerical densities. We obtained skeletal muscle biopsies from 17 male elite triathletes and road cyclists and 7 recreationally active men. Using quantitative transmission electron microscopy, we found that the endurance athletes had 2-3-fold greater LD-mitochondria contact length than the recreationally active individuals. This was related to higher numerical densities of both mitochondria and LDs in the intermyofibrillar space. Adding data from untrained individuals with equally high intermyofibrillar LD density as the endurance athletes revealed a 24% greater LD-mitochondria contact length in the endurance athletes. We observed small trivial differences in the shape of both organelles between populations. However, large mitochondrial profiles were more elongated and irregular in shape compared to small mitochondrial profiles, while large LD profiles were more circular and less irregular than small LD profiles. Within the group of athletes, large intermyofibrillar LD profiles correlated with a high fraction of PLIN5-positive LDs and their maximal fat oxidation rate was positively associated with an interaction between the profile size of both intermyofibrillar LDs and mitochondria. In conclusion, male endurance athletes have a greater LD-mitochondria contact than recreationally active and untrained individuals. This muscular phenotype is restricted to the intermyofibrillar space and to fibres rich in mitochondria.

physiology↗

Personalized Molecular Signatures of Insulin Resistance and Type 2 Diabetes

HighlightsO_LIAdvanced proteomics analysis reveals personalized signatures of insulin resistance C_LIO_LIFasting muscle proteome and phosphoproteome predicts whole-body insulin sensitivity C_LIO_LIInsulin-stimulated phosphoproteome reveals selective insulin resistance signatures C_LIO_LIPhosphoproteome and proteome atlas explains sex-specific muscle metabolism C_LI O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=143 SRC="FIGDIR/small/578994v1_ufig1.gif" ALT="Figure 1"> View larger version (35K): org.highwire.dtl.DTLVardef@a83000org.highwire.dtl.DTLVardef@1e77336org.highwire.dtl.DTLVardef@3d1ecdorg.highwire.dtl.DTLVardef@b1592b_HPS_FORMAT_FIGEXP M_FIG O_FLOATNOGraphical AbstractC_FLOATNO C_FIG Insulin resistance is a hallmark of type 2 diabetes, which is a highly heterogeneous disease with diverse pathology. Understanding the molecular signatures of insulin resistance and its association with individual phenotypic traits is crucial for advancing precision medicine in type 2 diabetes. Utilizing cutting-edge proteomics technology, we mapped the proteome and phosphoproteome of skeletal muscle from >120 men and women with normal glucose tolerance or type 2 diabetes, with varying degrees of insulin sensitivity. Leveraging deep in vivo phenotyping, we reveal that fasting proteome and phosphoproteome signatures strongly predict insulin sensitivity. Furthermore, the insulin-stimulated phosphoproteome revealed both dysregulated and preserved signaling nodes - even in individuals with severe insulin resistance. While substantial sex-specific differences in the proteome and phosphoproteome were identified, molecular signatures of insulin resistance remained largely similar between men and women. These findings underscore the need for precision medicine approaches in type 2 diabetes care, acknowledging disease heterogeneity.

biochemistry↗

The mitochondrial mRNA stabilizing protein, SLIRP, regulates skeletal muscle mitochondrial structure and respiration by exercise-recoverable mechanisms

Summary and graphical abstractDecline in mitochondrial function associates with decreased muscle mass and strength in multiple conditions, including sarcopenia and type 2 diabetes. Optimal treatment could include improving mitochondrial function, however, there are limited and equivocal data regarding the molecular cues controlling muscle mitochondrial plasticity. Here we uncover the mitochondrial-mRNA-stabilizing protein SLIRP, in complex with LRPPRC, as a PGC-1 target that regulates mitochondrial structure, respiration, and mitochondrially-encoded-mRNA pools in skeletal muscle. Exercise training effectively counteracted mitochondrial defects induced by loss of LRPPRC/SLIRP, despite sustained low mitochondrially-encoded-mRNA pools, via increased mitoribosome translation capacity. In humans, exercise training robustly increased muscle SLIRP and LRPPRC protein content across exercise modalities and sexes, yet this increase was less prominent in subjects with type 2 diabetes. Our work identifies a mechanism of post-transcriptional mitochondrial regulation in skeletal muscle through mitochondrial mRNA stabilization. It emphasizes exercise as an effective approach to alleviate mitochondrial defects by possibly increasing mitoribosome capacity. O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=142 SRC="FIGDIR/small/564600v2_ufig1.gif" ALT="Figure 1"> View larger version (61K): org.highwire.dtl.DTLVardef@1cdc6c5org.highwire.dtl.DTLVardef@b4cb1borg.highwire.dtl.DTLVardef@182871corg.highwire.dtl.DTLVardef@7462ea_HPS_FORMAT_FIGEXP M_FIG C_FIG

molecular biology↗

Metformin improves glycemia independently of skeletal muscle AMPK via enhanced intestinal glucose clearance

Metformin is an inexpensive oral anti-hyperglycemic agent used worldwide as a first-choice drug for the prevention of type 2 diabetes mellitus (T2DM). Although current view suggests that metformin exerts its anti-hyperglycemic effect by lowering hepatic glucose production, it has been proposed that metformin also reduce hyperglycemia by increasing glucose uptake in skeletal muscle via activation of AMP-activated protein kinase (AMPK). Herein, we demonstrate in lean and diet-induced obese (DIO) male and female mouse models that the anti-hyperglycemic effect of metformin occurs independently of muscle AMPK, and instead relies on elevated intestinal glucose clearance. Furthermore, we report that the AMPK activity is elevated in skeletal muscle from patients with T2DM following chronic metformin treatment, but this is not associated with enhanced peripheral insulin sensitivity. These results argue against existing paradigms and emphasize the non-essential role of muscle AMPK but important role of the intestine for the anti-hyperglycemic effect of metformin.

physiology↗